Name | AKTSIONERNOE OBSCHESTVO "PARMA MEDIKAL" |
|---|
INN | 7719031219 |
|---|
KPP | 771901001 |
|---|
OGRN | 1027700138465 |
|---|
OKPO | 11392762 |
|---|
FFSM | 18163-H |
|---|
Address | 105077, G.moskva, ul. Srednyaya Pervomayskaya, d. D.21 |
|---|
Phone | 225-73-22 Contact details |
|---|
Fax | 965-21-10 |
|---|
|
| OKVED code | Type | Name of activity type |
|---|
| 46.46 | Core activity | Wholesale of pharmaceutical goods | | 68.20.2 | Additional activity | Renting and operating of own or leased commercial properties and non- residential buildings | | 86.21 | Additional activity | General practice |
Registration date | 19.08.2002 |
|---|
Registering department | Gosudarstvennoe uchrezhdenie Moskovskaya registratsionnaya palata |
|---|
|
AO "PARMA MEDIKAL" (Moscow; INN 7719031219) was registered on 19 Aug 2002. The company's authorized capital as of July 1, 2012 was 1377000 rub. Type of ownership of AO "PARMA MEDIKAL" - Closed joint-stock companies. Form of ownership of AO "PARMA MEDIKAL" - Property of foreign legal entities. Principal activities of AO "PARMA MEDIKAL": wholesale of pharmaceutical goods (46.46), renting and operating of own or leased commercial properties and non- residential buildings (68.20.2), general practice (86.21). |
Economic indicators2024
Net profit (RAS) of AO PARMA MEDIKAL grew over 2024 by 15.18% to 21.29 million RUB from 18.49 million RUB over 2023, the company informed. Revenue increased in the accounting period by 10.85% to 1.21 billion RUB from 1.09 billion RUB over 2023; cost of goods sold grew by 12.00% to 935.19 million RUB from 835.01 million RUB; sales loss grew by 41.01% to 76.13 million RUB from 53.99 million RUB. 2023
Net profit (RAS) of AO PARMA MEDIKAL grew over 2023 2.24 times to 18.49 million RUB from 8.26 million RUB over 2022, the company informed. Revenue decreased in the accounting period by 14.63% to 1.09 billion RUB from 1.28 billion RUB in 2022; cost of goods sold decreased by 13.97% to 835.01 million RUB from 970.56 million RUB; sales loss decreased by 7.76% to 53.99 million RUB from 58.53 million RUB. 2022
Net profit (RAS) of AO PARMA MEDIKAL grew over 2022 1.59 times to 8.26 million RUB from 5.20 million RUB over 2021, the company informed. Revenue increased in the accounting period by 17.66% to 1.28 billion RUB from 1.09 billion RUB over 2021; cost of goods sold grew by 22.71% to 970.56 million RUB from 790.93 million RUB; sales loss grew 15.52 times to 58.53 million RUB from 3.77 million RUB. 2021
Net profit (RAS) of AO PARMA MEDIKAL dropped in 2021 2.24 times to 5.20 million RUB from 11.66 million RUB over the same period in 2020, the company informed. Revenue increased in the accounting period by 30.06% to 1.09 billion RUB from 834.56 million RUB over 2020; cost of goods sold grew by 32.06% to 790.93 million RUB from 598.91 million RUB; sales loss grew 10.17 times to 3.77 million RUB from 371.00 thousand RUB. 2020
Net profit (RAS) of AO PARMA MEDIKAL grew over 2020 16.85 times to 11.66 million RUB from 692.00 thousand RUB over 2019, the company informed. Revenue increased in the accounting period by 9.56% to 834.56 million RUB from 761.71 million RUB over 2019; cost of goods sold decreased by 0.76% to 598.91 million RUB from 603.50 million RUB; sales loss decreased 149.78 times to 371.00 thousand RUB from 55.57 million RUB. 2019
Net profit (RAS) of AO PARMA MEDIKAL grew over 2019 3.23 times to 692.00 thousand RUB from 214.00 thousand RUB over 2018, the company informed. Revenue increased in the accounting period by 14.59% to 761.71 million RUB from 664.71 million RUB over 2018; cost of goods sold grew by 9.92% to 603.50 million RUB from 549.02 million RUB; sales loss grew by 38.36% to 55.57 million RUB from 40.16 million RUB. 2018
Net profit (RAS) of AO PARMA MEDIKAL dropped in 2018 12.39 times to 214.00 thousand RUB from 2.65 million RUB over the same period in 2017, the company informed. Revenue decreased in the accounting period by 8.88% to 664.71 million RUB from 729.49 million RUB in 2017; cost of goods sold decreased by 5.86% to 549.02 million RUB from 583.20 million RUB; sales loss grew 1.96 times to 40.16 million RUB from 20.48 million RUB. 2017
Net profit (RAS) of AO PARMA MEDIKAL dropped in 2017 2.03 times to 2.65 million RUB from 5.37 million RUB over the same period in 2016, the company informed. Revenue decreased in the accounting period by 16.13% to 729.49 million RUB from 869.74 million RUB in 2016; cost of goods sold decreased by 14.89% to 583.20 million RUB from 685.22 million RUB; sales loss made up 20.48 million RUB compared to sales profit of 5.17 million RUB. 2016
Net profit (RAS) of AO PARMA MEDIKAL dropped in 2016 3.93 times to 5.37 million RUB from 21.11 million RUB over the same period in 2015, the company informed. Revenue decreased in the accounting period by 13.45% to 869.74 million RUB from 1.01 billion RUB in 2015; cost of goods sold decreased by 10.84% to 685.22 million RUB from 768.53 million RUB; sales profit fell 5.36 times to 5.17 million RUB from 27.72 million RUB. 2014
Net profit (RAS) of PARMA MEDIKAL, ZAO dropped in 2014 by 30.75% to 26.94 million RUB from 38.90 million RUB over the same period in 2013, the company informed. Revenue increased in the accounting period by 4.03% to 860.80 million RUB from 827.42 million RUB over 2013; cost of goods sold remained at the same level amounting to 661.54 million RUB compared to 660.42 million RUB; sales profit went up 1.93 times to 12.03 million RUB from 6.24 million RUB. 2013
Net profit (RAS) of PARMA MEDIKAL, ZAO grew over 2013 8.43 times to 38.90 million RUB from 4.62 million RUB over 2012, the company informed. Revenue increased in the accounting period by 17.99% to 827.42 million RUB from 701.24 million RUB over 2012; cost of goods sold grew by 10.36% to 660.42 million RUB from 598.40 million RUB; sales profit made up 6.24 million RUB compared to sales loss of 15.43 million RUB. 2012
Net profit (RAS) of Parma Medikal, ZAO grew over 2012 2.01 times to 4.62 million RUB from 2.30 million RUB over 2011, the company informed. Cost of goods sold grew by 22.00% to 598.40 million RUB from 490.51 million RUB; sales loss grew by 6.13% to 15.43 million RUB from 14.54 million RUB.
unlimited access to database "Kontragent" download any information within 24 hours
Companies in the region
|